2024
AbbVie Golden Ticket
Apply by October 27, 2024
AbbVie and BioLabs Europe invite you to apply for up to two Golden Tickets. The Golden Ticket provides a lab bench and office space, and a membership for one year, and access to the AbbVie team of scientific and industry advisors.
Golden Ticket Benefits
Application requirements
AbbVie is looking for early-stage biotech companies that fit the following criteria:
Focused on science / technology with potential to generate transformational therapies in areas that align strategically with AbbVie’s therapeutic areas of interest (listed below and available here)
Developing therapeutic platform technologies, including gene therapy, novel drug-discovery or platform technologies
Exclusions: Diagnostics, Devices, Research Tools, and Healthcare Services/IT
Therapeutic Areas at a Glance
Additional Requirements
-
Companies must have their principal place of business in the Heidelberg or Paris area or be willing to relocate to one of the locations
​
-
Companies must not have a significant partnership with another large biopharmaceutical company
-
However, current, or prior recipients of similar awards sponsored by other pharmaceutical companies or lab spaces are eligible to apply
-
​
-
Companies must meet Biolabs' Golden Ticket criteria:
-
Total equity funding raised must be less than $7.5M USD before the Golden Ticket is issued to them
-
Companies must not have trailing 12-month revenues in excess of $3M USD
-
Companies must be in the life sciences and have an impact on human health
-
​Companies must be financially and scientifically ready to move into Biolabs Heidelberg or Paris within three months of receiving the ticket
-
The Application Process
01
Submit applications by
October 27, 2024
02
A subset of applications will be identified as finalist by the contest judges by
November 1, 2024
03
Finalists will present their company & scientific concept at a virtual event
on November 13 or 14, 2024​
04
Up to 2 awards will be granted
Good luck!
Judging Criteria and Judges
AbbVie leaders who are qualified scientific experts in their respective fields, including specialties in scientific and/or medical research and business, will review all submissions. The following criteria will form application judging criteria:
Fit relating to the research fields of oncology, immunology, neuroscience, eye care, or aesthetics. Judges will also consider novel target(s) identification, drug delivery, discovery technology platforms, and translational research and development.
Quality of the scientific data, research plan and/or technology platform
Potential to successfully achieve research milestones and program development
Unmet need for the research in the relevant field. Is this research/program/technology addressing a critical medical need
Readiness to move into the Biolabs Heidelberg or Paris lab space within three months of being selected for the award
-
What is the Novo Nordisk Golden Ticket – Biolabs European Award?Golden Tickets are vouchers that Novo Nordisk can award to a startup company of their choice and provide that company with one lab bench for one year at two of BioLabs European hubs, either in Heidelberg, located in Germany or Paris in the hospital setting of Hôtel-Dieu, located in France. The value of a Golden Ticket prepays the cost of one (1) single bench, one (1) single desk and Biolabs membership for one person for one (1) year. The value of a single bench may be applied towards fees for a private lab in either Biolabs Heidelberg or Paris, pending availability at the time of their desired start. The Golden Ticket winner must pay the difference between the larger space and the value of the single bench covered by their Golden Ticket. If there are no benches available, the value of the golden ticket will be extended while the company remains on the waitlist for a bench. The winner will receive priority admission or renewal for one year’s use of a lab bench and access to all shared facilities at Biolabs Heidelberg or Paris, and opportunities to engage with Novo Nordisk scientific and business executives.
-
What is Novo Nordisk searching for?Please refer to section above: What is Novo Nordisk searching for?
-
How do I know if I am eligible for a Golden Ticket?Golden Tickets may be awarded to either startup companies that are interested in joining the Biolabs European community (either in Heidelberg or Paris) or current Resident Companies. To be eligible to participate to have the opportunity to receive the Award, the Applicant must: 1. Be an independent entity (SME); 2. Submit a complete Application; 3. Represent and warrant that the Applicant has read and agrees to abide by all requirements of terms and conditions ; 4. Not be affiliated with or employed by Novo Nordisk or Biolabs including as an employee, contractor, officer or director of Novo Nordisk or Biolabs and including as an immediate family member of Novo Nordisk or Biolabs (including parents, spouses, children, siblings or any individual residing in the household of a Novo Nordisk, officer or director (whether or not related)); 5. Not be an academic institution such as a college, university or school.
-
When will I be able to use my Golden Ticket?Winning teams will be invited to present their company & scientific concept at a live event in Paris on March 11, 2025 Companies must be financially and scientifically ready to start the program within three months of receiving the ticket and to execute the submitted research plan.
-
Where can I find more details on Novo Nordisk’s areas of focus for external innovation?Please refer to our Novo Nordisk creatioNN website page
-
How to apply and what should the application contain?Fill in our application form and submit it latest until January 20, 2025. The application should give an overview on your project, describe unmet medical need, solution, scientific principal, key data supporting the scientific principal and mechanism of action, the research plan and what is the key milestone to reach within one year, team competency, initial business and funding strategy, and IP status. You are also required to provide a non-confidential deck (max. 10 slides).
Contact Us
